Compare AMP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With more than $1 trillion in segment assets under management and advisory at year-end 2024, and with roughly 10,000 affiliated advisors, Ameriprise is one of the larger US-based wealth managers. The firm also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $645 billion in assets under management at year-end 2024. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.5 trillion in assets under management and advisory across segments at year-end 2024.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.